非培养真皮与表皮细胞悬液联合移植对比单用表皮细胞悬液治疗白癜风的疗效:一项随机临床试验
该单中心随机临床试验纳入40例临床稳定期3至6个月或超过12个月的局限型、节段型或泛发型白癜风患者,按稳定期分为两组各20例,每组再随机分为A、B亚组,分别接受非培养表皮细胞悬液(NCES)单用或NCES联合非培养真皮细胞悬液(NDCS)移植。结果显示,稳定期3至6个月组中联合移植亚组24周时超过75%复色者为10例中10例,而NCES单用亚组为10例中3例(100% vs 30%,P = .003);稳定期超过12个月组两亚组分别为10例中6例与10例中7例(60% vs 70%,P > .99)。作者认为联合移植在稳定期较短的患者中效果优良,可在稳定期早期使用。
要点
- 稳定期3至6个月患者中,NCES联合NDCS组24周超过75%复色10例中10例,NCES单用组10例中3例。
- 稳定期超过12个月患者中,两亚组超过75%复色分别为10例中6例与10例中7例,差异无统计学意义。
- 各组及各亚组在颜色匹配和复色模式上均未见显著差异。
核心结论
- NCES联合NDCS在临床稳定期较短(3至6个月)的白癜风患者中较单用NCES取得优良的复色反应。
- 作者认为该联合方案可在稳定期白癜风病程早期使用,无需等待距末次临床活动12个月或更久。
研究设计与样本
- 单中心随机临床试验,纳入40例局限型、节段型或泛发型白癜风患者,稳定期3至6个月或超过12个月。
- 按稳定期分2组,每组20例(组1稳定期3至6个月,组2稳定期超过12个月),每组再随机分为A、B两个亚组。
- 亚组1A和2A接受NCES单用,亚组1B和2B接受NCES联合NDCS。
- 主要结局为24周时复色程度、颜色匹配和复色模式。
- 试验注册号:ClinicalTrials.gov NCT03013049。
主要发现
- 40例参与者平均(SD)年龄24.9(4.0)岁,其中女性24例(60%)。
- 组1(稳定期3至6个月)24周时超过75%复色:亚组1B(NCES联合NDCS)10例中10例,亚组1A(NCES)10例中3例(100% vs 30%,P = .003)。
- 组2(稳定期超过12个月)超过75%复色:亚组2A 10例中6例,亚组2B(原文此处写作NCES)10例中7例(60% vs 70%,P > .99)。
- 两组及各亚组在颜色匹配和复色模式方面均未见显著差异。
关键数值与推荐
- 组1中超过75%复色比例:亚组1B为100%(10例中10例)vs 亚组1A为30%(10例中3例),P = .003。
- 组2中超过75%复色比例:亚组2A为60%(10例中6例)vs 亚组2B为70%(10例中7例),P > .99。
- 原文组2结果处将亚组2B写作NCES,按上下文应为NCES联合NDCS。
临床怎么用
- 作者认为,NCES联合NDCS可在稳定期白癜风病程早期使用,无需等待距末次临床活动12个月或更久。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Surgical interventions, notably noncultured epidermal suspension (NCES), are the next line of treatment in patients with vitiligo who fail to respond to medical therapy. Noncultured epidermal suspension is usually performed in patients with vitiligo with duration of clinical stability (DS) of 12 months or longer because DS is a vital parameter in determining outcome of NCES. In this pilot study, we planned to assess the efficacy of a novel combination of noncultured epidermal cell suspension and noncultured dermal cell suspension (NCES and NDCS) in patients with vitiligo with shorter DS (3-6 months). OBJECTIVE: To compare the efficacy of transplantation of NCES and NDCS vs NCES alone in patients with vitiligo with DS of 3 to 6 months. DESIGN, SETTING, AND PARTICIPANTS: A single-center randomized clinical trial including 40 patients with focal, segmental, or generalized vitiligo with DS of 3 to 6 months or more than 12 months was carried out. Based on DS, 2 groups including 20 patients each were recruited (DS in group 1, 3 to 6 months; DS in group 2, more than 12 months). Each group was further randomized into 2 subgroups, A and B. INTERVENTION: Patients in subgroups 1A and 2A underwent NCES alone, whereas patients in subgroups 1B and 2B underwent NCES and NDCS. MAIN OUTCOMES AND MEASURES: Extent of repigmentation, color match, and pattern of repigmentation at 24 weeks. RESULTS: Of the 40 study participants, mean (SD) age was 24.9 (4.0) years and 24 (60%) were women; in group 1 with DS for 3 to 6 months, more than 75% repigmentation at 24 weeks was observed in all 10 patients in subgroup 1B (NCES and NDCS) compared with 3 of 10 patients in subgroup 1A (NCES) (100% vs 30%, P = .003). In group 2 (DS > 12 months), the same was observed in 6 of 10 patients in subgroup 2A and 7 of 10 patients in subgroup 2B (NCES) (60% vs 70%, P > .99). The 2 groups and subgroups did not show any significant differences with respect to color matching and pattern of repigmentation. CONCLUSIONS AND RELEVANCE: Combination of NCES and NDCS resulted in excellent response in patients with vitiligo with shorter duration of clinical stability compared with NCES alone. This combination may be used early in the course of stable vitiligo without waiting for a period of 12 months or more since last clinical activity. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT03013049.
引用
- Thakur V, Kumar S, Kumaran MS, et al. Efficacy of Transplantation of Combination of Noncultured Dermal and Epidermal Cell Suspension vs Epidermal Cell Suspension Alone in Vitiligo: A Randomized Clinical Trial. JAMA Dermatol. 2019. PMID: 30601885. doi:10.1001/jamadermatol.2018.4919
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。